Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mengni Guo

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Chinese Clinical Oncology|November 21, 2022
GEMSTONE-302: "If you keep doing the same thing you get the same result"Mengni Guo, Jieying Liu, Tarek Mekhail, et al.
BMJ Case Reports|June 6, 2022
Primary breast diffuse large B cell lymphomaMengni Guo, Jieying Liu, Richard Gilmore, et al.
Cureus|May 27, 2022
A Case Report of Reversible Cerebral Vasoconstriction Syndrome in a Patient With Systemic SclerodermaJieying Liu, Mengni Guo, Richard D Beegle, et al.
Clinical Lung Cancer|September 1, 2022
Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse EventsMengni Guo, Ari M VanderWalde, Xinhua Yu, et al.
International Journal of Hematology|November 15, 2022
Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experienceMengni Guo, Jieying Liu, Pamela Clark, et al.
Transplantation and Cellular Therapy|September 25, 2025
Comparison of Fresh Versus Frozen Allogenic Peripheral Blood Stem Cell Grafts in Hematopoietic Stem Cell Transplantation: A Meta-Analysis and Systematic ReviewDarren Wijaya, Riyan Bittar, Pranati Shah, et al.
SN Comprehensive Clinical Medicine|August 31, 2022
COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint InhibitorsMengni Guo, Jieying Liu, Shuntai Zhou, et al.
Frontiers in Cardiovascular Medicine|September 15, 2025
Management of intermediate high-risk pulmonary embolism: a single-center retrospective studyFortune O Alabi, Ashkan Ghaneie, Ibrahim Koury, et al.
Journal of Gastrointestinal Oncology|May 19, 2025
Biomarker-driven therapeutic strategies in advanced gastric cancer: a case series of curative responsesDaniel Park, Lu Pu, Mengni Guo, et al.
Annals of Hematology|December 3, 2022
Evaluation of different pharmacokinetically guided IV busulfan exposure ranges on adult patient outcomes after hematopoietic stem cell transplantationShahram Mori, Mengni Guo, Nahir Rivera-Robles, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Chinese Clinical Oncology|November 21, 2022
GEMSTONE-302: "If you keep doing the same thing you get the same result"Mengni Guo, Jieying Liu, Tarek Mekhail, et al.
BMJ Case Reports|June 6, 2022
Primary breast diffuse large B cell lymphomaMengni Guo, Jieying Liu, Richard Gilmore, et al.
Cureus|May 27, 2022
A Case Report of Reversible Cerebral Vasoconstriction Syndrome in a Patient With Systemic SclerodermaJieying Liu, Mengni Guo, Richard D Beegle, et al.
Clinical Lung Cancer|September 1, 2022
Immune Checkpoint Inhibitor Rechallenge Safety and Efficacy in Stage IV Non-Small Cell Lung Cancer Patients After Immune-Related Adverse EventsMengni Guo, Ari M VanderWalde, Xinhua Yu, et al.
International Journal of Hematology|November 15, 2022
Cryopreserved versus fresh peripheral blood allogeneic stem cell transplantation outcomes in patients receiving post-transplant cyclophosphamide for graft-versus-host prophylaxis during the COVID-19 pandemic: a single center experienceMengni Guo, Jieying Liu, Pamela Clark, et al.
Transplantation and Cellular Therapy|September 25, 2025
Comparison of Fresh Versus Frozen Allogenic Peripheral Blood Stem Cell Grafts in Hematopoietic Stem Cell Transplantation: A Meta-Analysis and Systematic ReviewDarren Wijaya, Riyan Bittar, Pranati Shah, et al.
SN Comprehensive Clinical Medicine|August 31, 2022
COVID-19 Outcomes in Stage IV Cancer Patients Receiving Immune Checkpoint InhibitorsMengni Guo, Jieying Liu, Shuntai Zhou, et al.
Frontiers in Cardiovascular Medicine|September 15, 2025
Management of intermediate high-risk pulmonary embolism: a single-center retrospective studyFortune O Alabi, Ashkan Ghaneie, Ibrahim Koury, et al.
Journal of Gastrointestinal Oncology|May 19, 2025
Biomarker-driven therapeutic strategies in advanced gastric cancer: a case series of curative responsesDaniel Park, Lu Pu, Mengni Guo, et al.
Annals of Hematology|December 3, 2022
Evaluation of different pharmacokinetically guided IV busulfan exposure ranges on adult patient outcomes after hematopoietic stem cell transplantationShahram Mori, Mengni Guo, Nahir Rivera-Robles, et al.
Pageof 2